Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Regulatory News (APH)

  • This share is currently suspended. It was suspended at a price of 64.70
  • There is currently no data for APH

Form 8.3 ALLIANCE PHARMA PLC

17 Apr 2025 13:22

RNS Number : 5088F
Barclays PLC
17 April 2025
 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

 

Barclays PLC.

(b)

Owner or controller of interest and short

 

 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

ALLIANCE PHARMA PLC

 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

 

 

offeror/offeree, state this and specify identity of

 

offeror/offeree:

(e)

Date position held/dealing undertaken:

16 Apr 2025

(f)

In addition to the company in 1(c) above, is the discloser making

NO

 

 

 

disclosures in respect of any other party to the offer?

 

 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

 

 

to which the disclosure relates following the dealing(if any)

 

Class of relevant security:

1p ordinary

 

Interests

Short Positions

 

Number

(%)

Number

(%)

(1)

Relevant securities owned

 

 

 

 

 

and/or controlled:

 

 

5,741,923

1.06%

1,956,258

0.36%

(2)

Cash-settled derivatives:

 

 

 

 

 

and/or controlled:

 

 

1,063,873

0.20%

5,741,834

1.06%

(3)

Stock-settled derivatives (including options)

 

 

 

 

 

and agreements to purchase/sell:

 

 

0

0.00%

0

0.00%

 

 

 

 

 

 

 

 

 

TOTAL:

 

 

6,805,796

1.26%

7,698,092

1.42%

(b)

Rights to subscribe for new securities (including directors and other executive

 

 

options)

 

 

 

 

 

 

Class of relevant security in relation to

 

 

 

 

which subscription right exists

 

 

 

 

Details, including nature of the rights

 

 

 

 

concerned and relevant percentages:

 

 

 

 

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

 

 

 

 

 

Class of relevant

Purchase/sale

Number of

Price per unit

security

 

securities

 

1p ordinary

Purchase

39,648

0.6420 GBP

1p ordinary

Purchase

14,994

0.6430 GBP

1p ordinary

Sale

43,918

0.6424 GBP

1p ordinary

Sale

35,540

0.6420 GBP

1p ordinary

Sale

14,951

0.6419 GBP

 

 

 

 

 

 

 

 

(b)

Cash-settled derivative transactions

 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

 

reference

unit

security

 

 

securities

 

1p ordinary

SWAP

Decreasing Short

12,863

0.6419 GBP

1p ordinary

SWAP

Decreasing Short

23,698

0.6420 GBP

1p ordinary

SWAP

Decreasing Short

42,076

0.6424 GBP

1p ordinary

SWAP

Increasing Short

25,538

0.6420 GBP

1p ordinary

SWAP

Increasing Short

14,994

0.6430 GBP

 

 

 

 

 

 

 

 

(c)

Stock-settled derivative transactions (including options)

 

(i)

Writing, selling, purchasing or varying

 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

 

date

money

relevant

 

selling,

securities

per unit

 

 

paid/

security

 

varying etc

to which

 

 

 

received

 

 

 

option

 

 

 

per unit

 

 

 

relates

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii)

Exercising

 

 

 

 

 

 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

 

 

securities

unit

 

 

 

 

 

 

 

 

 

 

 

 

 

(d)

Other dealings (including subscribing for new securities)

 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

 

 

applicable)

 

 

 

 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,

 

 

formal or informal, relating to relevant securities which may be an inducement to deal

 

 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

 

to the offer or any person acting in concert with a party to the offer:

 

 

 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between

 

 

the person making the disclosure and any other person relating to:

 

 

(i) the voting rights of any relevant securities under any option; or

 

 

 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

 

 

any derivative is referenced:

 

 

 

 

 

 

NONE

(c)

Attachments

 

 

 

 

 

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

17 Apr 2025

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETIRMBTMTABBBA
Date   Source Headline
23rd May 20243:09 pmRNSSuccessful appeal of CMA decision
22nd May 20247:00 amRNSNotification of Major Interest in Shares
15th May 20249:14 amRNSNotification of Major Holdings
8th May 20247:00 amRNSFurther Update on Preliminary Results
8th May 20247:00 amRNSManagement Update
26th Apr 20247:00 amRNSPreliminary Results Publication Date
22nd Apr 20247:00 amRNSFurther update on timing of preliminary results
5th Apr 20247:00 amRNSUpdate on Timing of Preliminary Results
2nd Apr 202411:12 amRNSTotal Voting Rights
4th Mar 20248:00 amRNSTotal Voting Rights
4th Mar 20247:00 amRNSNotification of Full Year Results
5th Feb 20247:00 amRNSNew Chair Appointment
29th Jan 20247:00 amRNSFull Year Trading Update
2nd Jan 202410:51 amRNSBlock Listing Six Monthly Return
1st Dec 202312:23 pmRNSTotal Voting Rights
9th Nov 202311:17 amRNSNotification of Major Holdings
7th Nov 20237:00 amRNSAppointment of Non-Executive Directors
1st Nov 202312:50 pmRNSTotal Voting Rights
16th Oct 20236:13 pmRNSDirector Dealings
12th Oct 20232:51 pmRNSNotification of Major Interest in Shares
5th Oct 20234:39 pmRNSGrant of Options to Directors
2nd Oct 20233:14 pmRNSTotal Voting Rights
26th Sep 20237:00 amRNSInterim Results
22nd Sep 20235:28 pmRNSNotification of Major Holdings
4th Sep 20231:19 pmRNSNotification of Major Holdings
30th Aug 20234:29 pmRNSNotification of Major Holdings
29th Aug 202311:32 amRNSNotification of Major Holdings
15th Aug 20231:55 pmRNSNotification of Major Holdings
10th Aug 20237:00 amRNSNotification of Half Year Results
20th Jul 20239:54 amRNSDirector Dealing
19th Jul 20237:00 amRNSDirector Dealings
18th Jul 20237:00 amRNSHalf Year Trading Update
3rd Jul 20233:05 pmRNSTotal Voting Rights
29th Jun 20237:00 amRNSBlock Listing Six Monthly Return
1st Jun 20235:16 pmRNSTotal Voting Rights
25th May 202312:44 pmRNSResult of AGM
25th May 20237:00 amRNSAGM Statement
3rd May 202312:25 pmRNSTotal Voting Rights
3rd May 202312:08 pmRNSNotification of Major Holdings
12th Apr 202310:00 amRNSAnnual Report and Notice of AGM
5th Apr 202311:00 amRNSNotification of Major Holdings
4th Apr 202310:46 amRNSNotification of Major Holdings
3rd Apr 202310:04 amRNSTotal Voting Rights
31st Mar 20233:00 pmRNSNotification of Major Holdings
29th Mar 20237:00 amRNSNotification of Major Holdings
21st Mar 20234:59 pmRNSNotification of Major Holdings
21st Mar 20237:00 amRNSPreliminary Results
14th Mar 20231:47 pmRNSNotification of Major Holdings
7th Mar 202312:51 pmRNSNotification of Major Holdings
23rd Feb 20237:00 amRNSNotification of Full Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.